Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $694,602 | $511,007 | $508,913,294 | $490,088,069 |
| - Cash | $42,012 | $18,749 | $18,348 | $22,261 |
| + Debt | $1,831 | $1,970 | $2,106 | $2,237 |
| Enterprise Value | $654,421 | $494,228 | $508,897,052 | $490,068,045 |
| Revenue | $861 | $836 | $868 | $140 |
| % Growth | 3% | -3.7% | 520% | – |
| Gross Profit | $812 | $790 | $824 | $75 |
| % Margin | 94.3% | 94.5% | 94.9% | 53.6% |
| EBITDA | $81 | -$19,327 | -$18,921 | -$26,055 |
| % Margin | 9.4% | -2,311.8% | -2,179.8% | -18,611.1% |
| Net Income | -$20,828 | -$19,363 | -$18,755 | -$26,212 |
| % Margin | -2,419% | -2,316.1% | -2,160.7% | -18,722.9% |
| EPS Diluted | -0.4 | -0.5 | -0.49 | -1.66 |
| % Growth | 20% | -2% | 70.5% | – |
| Operating Cash Flow | -$14,550 | -$15,527 | -$16,616 | -$36,177 |
| Capital Expenditures | -$310 | -$34 | -$112 | -$254 |
| Free Cash Flow | -$14,860 | -$15,561 | -$16,728 | -$36,431 |